Five‐year risk of cardiovascular events in women with history of pregnancy complicated by fetal growth restriction

OBJECTIVE: To evaluate the association between fetal growth restriction (FGR) and adverse maternal cardiovascular outcomes within 5 years postpartum. METHODS: This was a retrospective study that used a global federated health research network (TriNetX) in which diagnoses are coded using the International Classification of Diseases, tenth revision, Clinical Modification system (ICD-10-CM). Nulliparous women aged ≥ 18 years, without prior cardiovascular disease and with a singleton pregnancy delivered between April 2006 and December 2020, were categorized by the presence or absence of FGR (ICD-10-CM: O36.5). 1:1 propensity-score matching (PSM) was applied using two models: Model 1, matching for pre-existing cardiovascular risk factors; and Model 2, matching for both pre-existing and other pregnancy-related cardiovascular risk factors. Cox regression proportional hazard models were used to estimate hazard ratios (HRs) with 95% CI for a maternal composite cardiovascular outcome including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke within 5 years postpartum, and for each of these components individually. RESULTS: After PSM, 84 863 women per group were analyzed in Model 1 and 84 861 per group in Model 2. FGR was associated with an increased risk of the composite cardiovascular outcome (Model 1: HR, 1.33 (95% CI, 1.16-1.52); Model 2: HR, 1.31 (95% CI, 1.15-1.50)), as well as with an increased risk of each of the components of the composite outcome individually: heart failure (Model 1: HR, 1.29 (95% CI, 1.08-1.54); Model 2: HR, 1.30 (95% CI, 1.09-1.56)), acute myocardial infarction (Model 1: HR, 1.55 (95% CI, 1.16-2.08); Model 2: HR, 1.53 (95% CI, 1.15-2.05)) and cerebral infarction/ischemic stroke (Model 1: HR, 1.38 (95% CI, 1.09-1.74); Model 2: HR, 1.33 (95% CI, 1.06-1.68)) within 5 years postpartum. CONCLUSIONS: FGR in a first pregnancy is associated with increased maternal composite cardiovascular risk, including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke, within 5 years postpartum. These findings suggest that FGR may be a marker of early cardiovascular vulnerability. However, residual confounding, particularly by unmeasured timing or severity of pre-eclampsia, cannot be excluded. Also, FGR was identified using coding constructs based on electronic health records, which may include overlap with broader 'suspected poor growth' phenotypes such as small-for-gestational age, hence potentially diluting the observed associations. Earlier risk assessment and preventive strategies may help to reduce the risk of long-term morbidity and mortality in this population. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Authors

Institutions

Publication Details

Journal
Ultrasound in Obstetrics and Gynecology
Published
2026-11-18
DOI
https://doi.org/10.1002/uog.70387
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Five‐year risk of cardiovascular events in women with history of pregnancy complicated by fetal growth restriction

Keerthana Anand, Tommaso Bucci, Abi Merriel, Gregory Y.H. Lip et al.
3 links
Ultrasound in Obstetrics and Gynecology
Pregnancy and preeclampsia studies
article

Five‐year risk of cardiovascular events in women with history of pregnancy complicated by fetal growth restriction

Keerthana Anand, Tommaso Bucci, Abi Merriel, Gregory Y.H. Lip, Maria Sudell
article en

Abstract

OBJECTIVE: To evaluate the association between fetal growth restriction (FGR) and adverse maternal cardiovascular outcomes within 5 years postpartum. METHODS: This was a retrospective study that used a global federated health research network (TriNetX) in which diagnoses are coded using the International Classification of Diseases, tenth revision, Clinical Modification system (ICD-10-CM). Nulliparous women aged ≥ 18 years, without prior cardiovascular disease and with a singleton pregnancy delivered between April 2006 and December 2020, were categorized by the presence or absence of FGR (ICD-10-CM: O36.5). 1:1 propensity-score matching (PSM) was applied using two models: Model 1, matching for pre-existing cardiovascular risk factors; and Model 2, matching for both pre-existing and other pregnancy-related cardiovascular risk factors. Cox regression proportional hazard models were used to estimate hazard ratios (HRs) with 95% CI for a maternal composite cardiovascular outcome including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke within 5 years postpartum, and for each of these components individually. RESULTS: After PSM, 84 863 women per group were analyzed in Model 1 and 84 861 per group in Model 2. FGR was associated with an increased risk of the composite cardiovascular outcome (Model 1: HR, 1.33 (95% CI, 1.16-1.52); Model 2: HR, 1.31 (95% CI, 1.15-1.50)), as well as with an increased risk of each of the components of the composite outcome individually: heart failure (Model 1: HR, 1.29 (95% CI, 1.08-1.54); Model 2: HR, 1.30 (95% CI, 1.09-1.56)), acute myocardial infarction (Model 1: HR, 1.55 (95% CI, 1.16-2.08); Model 2: HR, 1.53 (95% CI, 1.15-2.05)) and cerebral infarction/ischemic stroke (Model 1: HR, 1.38 (95% CI, 1.09-1.74); Model 2: HR, 1.33 (95% CI, 1.06-1.68)) within 5 years postpartum. CONCLUSIONS: FGR in a first pregnancy is associated with increased maternal composite cardiovascular risk, including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke, within 5 years postpartum. These findings suggest that FGR may be a marker of early cardiovascular vulnerability. However, residual confounding, particularly by unmeasured timing or severity of pre-eclampsia, cannot be excluded. Also, FGR was identified using coding constructs based on electronic health records, which may include overlap with broader 'suspected poor growth' phenotypes such as small-for-gestational age, hence potentially diluting the observed associations. Earlier risk assessment and preventive strategies may help to reduce the risk of long-term morbidity and mortality in this population. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Ultrasound in Obstetrics and Gynecology
Medical University of Białystok (PL), University of Liverpool (GB), University of Perugia (IT), Liverpool Heart and Chest Hospital (GB), Liverpool Women's Hospital (GB), Liverpool John Moores University (GB), Aalborg University (DK)
National Institute for Health and Care Research, Department of Health and Social Care
Good health and well-being
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon